Male Infertility Market Expected to Claim $301.5 Million Value by 2020 : DNA fragmentation industry to grow with highest rates during forecast period

According to National Institutes of Health in the U.S. there are approximately >2 million infertile couples of which about 40% accounts to male infertility. The most common type of male infertility is the idiopathic infertility and infertility due to varicocele. The basic treatments involved in male infertility are surgery, treatment for problems in intercourse, hormone treatment and ART technology.

Male Infertility Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $301.5 million by 2020, registering a CAGR of 5% during the period 2014-2020.

Request Sample/ TOC Report @ https://www.alliedmarketresearch.com/request-sample/241

There is a steady increase in the global infertility rates both in the developed and developing nations. The changing life style, delayed pregnancy and aging are few of the factors driving the global infertility cases. The report excludes basic male infertility treatments such as surgery, treatment for problems in intercourse and hormonal treatment. The report focuses on male infertility and its treatment techniques with focus on drugs and devices. There are various techniques that are used in the diagnosis of the male infertility such as DNA fragmentation, oxidative stress, CASA (computer assisted semen analysis), sperm penetration assay, sperm agglutination and microscopic examination. The DNA fragmentation is an emerging technique which has already gained popularity and is accepted as a routine technique in the developed countries. The technique is yet to gain popularity in the developing regions and yet to be used as a routine technique due to the cost hindrance.

Infertility in male is characterized by various infertility related problems such as low sperm count, presence of low motile sperm or azoospermia. The various causes of male infertility include stress, consumption of alcohol or drugs, smoking, obesity, environmental toxins, etc. These factors also act as driving factors of the male infertility market. When an individual is diagnosed with infertility, the person undergoes immense stress, embarrassment and guilt, which would further intensify the infertility problem. This is a major limitation of this market. The opportunity for the growth of this market is the increase in awareness levels among men and rising trend in medical tourism.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/241

The male infertility market is segmented based on techniques, namely DNA fragmentation, oxidative stress analysis, sperm agglutination test, sperm penetration test, microscopic examination, computer assisted semen analysis and others. The DNA fragmentation would be the highest revenue generating market by 2020 and is also expected to have the highest CAGR during the analysis period, when compared to the other segments in the techniques market. This is due to the accuracy level the test provides in identifying the level of infertility by measuring the level of DNA damage.

The key companies profiled in the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions.

Male Infertility Market Segments covered in the report:

By Techniques

• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Penetration Assay
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Others

For More Info Visit @ https://www.alliedmarketresearch.com/press-release/male-infertility-market-is-expected-to-reach-301-5-million-globally-by-2020.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.